Skip to content

PR-Web

Press releases worldwide

  • Home
  • Contact
  • Datenschutzerklärung
  • Legal notice

Author: Firma BellaSeno

BellaSeno Starts Two Clinical Trials of its Resorbable Breast and Chest Implants

Posted on 4. August 2022 by Firma BellaSeno Posted in General Tagged absorbable, bellaseno, breast, cancer, excavatum, forsoft, hbi, implant, implants, patients, pectus, scaffold, senella, suture, with

  Resorbable implants to treat pectus excavatum and silicone breast implant revision / congenital defect correction First patients treated in Australia BellaSeno GmbH, an ISO 13485-certified medtech company developing resorbable scaffolds using additive manufacturing technologies, today announced the start of […]

Read More

BellaSeno Announces Publication of First-in-Human Data of its Lead Program Senella

Posted on 8. December 2021 by Firma BellaSeno Posted in General Tagged absorbable, bellaseno, bellaseno's, breast, clinical, excavatum, graft, implant, implants, medtech, patients, pectus, scaffold, senella, with

Successful initial treatment of pectus excavatum patient in Australia Data published in the European Journal of Plastic Surgery confirms Bellaseno’s novel approach in soft tissue engineering BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, […]

Read More

BellaSeno Appoints Tobias Grossner to Chief Medical Officer

Posted on 2. December 20212. December 2021 by Firma BellaSeno Posted in General Tagged absorbable, bellaseno, bone, breast, clinical, fraunhofer, grossner, heidelberg, implant, implants, patients, research, scaffold, senella, with

BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced the appointment of Dr. med. Tobias Grossner as Chief Medical Officer (CMO). Dr. Grossner brings strong clinical expertise in trauma surgery and regenerative medicine […]

Read More

BellaSeno Receives Australian Public Grant Totaling AUD 1 Million

Posted on 15. September 202115. September 2021 by Firma BellaSeno Posted in General Tagged absorbable, bellaseno, bone, breast, cancer, chhaya, evonik, honor, implant, implants, market, patients, scaffold, senella, with

Winner of the Australian Global Innovation Linkages Program Funding dedicated to advancing regenerative scaffolds for breast reconstruction and large bone defects BellaSeno to lead consortium of renowned commercial and academic partners BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable […]

Read More

BellaSeno Initiates Scaffold Development Program for Tendon and Ligament Regeneration

Posted on 1. July 20212. July 2021 by Firma BellaSeno Posted in Research / Development Tagged absorbable, bellaseno, bellaseno's, bone, breast, cell, chhaya, clinical, fraunhofer, implant, market, patients, scaffold, senella, with

. Collaboration with Fraunhofer IZI further expanded Funding provided by Sächsische Aufbaubank BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that the Company has initiated a program on tendon and ligament reconstruction […]

Read More

BellaSeno Wins Prestigious German Innovation Award 2021

Posted on 18. May 2021 by Firma BellaSeno Posted in General Tagged absorbable, bellaseno, bluechip, breast, chhaya, clinical, excavatum, implant, medtech, new, patients, pectus, scaffold, senella, with

BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced that the Company has received the German Innovation Award from the German Design Council for its Senella® technology in the category #W2 Excellence in Business […]

Read More

BellaSeno and Fraunhofer Institute for Production Technology IPT Receive EUR 1.4 Million BMBF Grant

Posted on 10. March 202110. March 2021 by Firma BellaSeno Posted in General Tagged absorbable, bellaseno, breast, cloud, fraunhofer, implant, implants, market, patients, printing, robot, robotics, scaffold, senella, with

Funding dedicated to the development of commercial-scale, fully automated additive manufacturing of resorbable medical implants First-ever industrial-scale, additive manufacturing platform of medical implants BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, and the Fraunhofer […]

Read More

BellaSeno Establishes GMP-Compliant High-Throughput Additive Manufacturing Facility for Resorbable Medical Implants

Posted on 17. November 2020 by Firma BellaSeno Posted in General Tagged absorbable, bellaseno, breast, cell, chhaya, clinical, fraunhofer, implant, implants, medtech, research, scaffold, senella, therapy, with

. – Seamless transition from R&D to commercial-scale additive manufacturing – Leading-edge cleanroom, no-touch manufacturing – GMP capabilities for internal and contract manufacturing BellaSeno GmbH, an ISO 13485-certified medtech company developing absorbable scaffolds using additive manufacturing technologies, today announced the […]

Read More

BellaSeno Announces First-In-Human Trial of its Novel, Absorbable Soft Tissue Reconstruction Scaffold and Granting of Key U.S. Patent

Posted on 21. July 2020 by Firma BellaSeno Posted in General Tagged absorbable, ades, bellaseno, breast, chhaya, clinical, endpoint, implant, implants, medtech, patients, scaffold, senella, syndrome, with

First patient with Pectus Excavatum congenital defect has undergone surgery in Australia Minimally invasive procedure and fully absorbable scaffold expected to provide for improved safety and recovery Key U.S. patent granted for the design and porosity of Senella® platform BellaSeno […]

Read More

Copyright 2016. All rights reserved.


Back To Top
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkRead more